☆ 4.7 Article

Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo

MOLECULAR THERAPY (2022)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation

Yao-Chun Hsu et al.

Summary: This study aimed to assess the effect of viral inhibition on hepatocellular carcinogenesis of hepatitis B virus (HBV) infection and explore the correlation between viral integrations and host gene dysregulation. The results showed that viral inhibition can reduce the number of transcriptionally active viral integrations and viral integrations are significantly correlated with host gene dysregulation.

GASTROENTEROLOGY (2022)

Add to Collection

Review Virology

Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas

Yu-Chan Yang et al.

Summary: Hepatitis B virus (HBV) infection remains a global public health issue, and the current antiviral therapy fails to cure it. CRISPR-mediated gene editing has emerged as a promising approach for HBV cure, but it faces challenges such as off-target effects and difficulty in finding conserved target sequences.

VIRUSES-BASEL (2022)

Add to Collection

Article Multidisciplinary Sciences

Ongoing viral replication and production of infectious virus in patients with chronic hepatitis B virus suppressed below the limit of quantitation on long-term nucleos(t)ide therapy

Dara L. Burdette et al.

Summary: Nucleos(t)ide analogs are standard treatment for chronic hepatitis B but do not eliminate the viral episome, leading to the presence of residual infectious virus in some treated patients. Additional treatment intensification may be necessary to achieve a cure.

PLOS ONE (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

Long-term stable reduction of low-density lipoprotein in nonhuman primates following in vivo genome editing of PCSK9

Lili Wang et al.

Summary: The study demonstrates the lasting therapeutic effect of targeted gene disruption through lowering specific protein levels with no obvious adverse changes, providing important data support for the treatment of hypercholesterolemia.

MOLECULAR THERAPY (2021)

Add to Collection

Article Medicine, Research & Experimental

CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice

Daniel Stone et al.

Summary: The study utilized AAV and CRISPR-SaCas9 for gene editing therapy in liver-humanized FRG mice chronically infected with HBV, showing improved treatment efficacy by enhancing gene editing levels, which significantly impacted HBV infection.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)

Add to Collection

Article Virology

Targeted Long-Read Sequencing Reveals Comprehensive Architecture, Burden, and Transcriptional Signatures from Hepatitis B Virus-Associated Integrations and Translocations in Hepatocellular Carcinoma Cell Lines

Ricardo Ramirez et al.

Summary: This study utilized genomics approaches to describe HBV integrations and transcriptional signatures in three HCC cell lines, revealing potential associations between HBV and host chromosomal translocations. The application of novel methods sheds new light on the complexity and potential risks of HBV integrations in HCC.

JOURNAL OF VIROLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo

Ugne Zekonyte et al.

Summary: This study shows the potential of using mitoARCUS, a mitochondrial-targeted gene editing platform, to specifically eliminate mutant mtDNA with a m.5024C>T mutation in the mt-tRNA(Ala) gene. MitoARCUS was successful in robustly eliminating mutant mtDNA in the liver and skeletal muscle of mice, demonstrating its promise as a powerful tool for the treatment of heteroplasmic mitochondrial DNA mutations.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Microbiology

Inhibition of Hepatitis B Virus by AAV8-Derived CRISPR/SaCas9 Expressed From Liver-Specific Promoters

Kun Yan et al.

Summary: Genome editing technology CRISPR/Cas may hold potential in treating chronic hepatitis B virus infection, especially when combined with liver-specific promoters to effectively inhibit HBV replication, while ensuring safety is essential. The study results are helpful for restricting the effects of the CRISPR/Cas9 system to the liver in clinical applications, thereby reducing the probability of nonspecific targeting in other organs.

FRONTIERS IN MICROBIOLOGY (2021)

Add to Collection

Review Multidisciplinary Sciences

The promise and challenge of therapeutic genome editing

Jennifer A. Doudna

NATURE (2020)

Add to Collection

Article Gastroenterology & Hepatology

Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection

Nina Le Bert et al.

GASTROENTEROLOGY (2020)

Add to Collection

Article Medicine, Research & Experimental

Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing

Yu-Chan Yang et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

Add to Collection

Article Multidisciplinary Sciences

Genomic modeling of hepatitis B virus integration frequency in the human genome

Ondrej Podlaha et al.

PLOS ONE (2019)

Add to Collection

Article Pharmacology & Pharmacy

HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory element

Tianlun Zhou et al.

ANTIVIRAL RESEARCH (2018)

Add to Collection

Article Gastroenterology & Hepatology

Towards HBV curative therapies

Raymond F. Schinazi et al.

LIVER INTERNATIONAL (2018)

Add to Collection

Article Biotechnology & Applied Microbiology

Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol

Lili Wang et al.

NATURE BIOTECHNOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Detection of hyper-conserved regions in hepatitis B virus X gene potentially useful for gene therapy

Carolina Gonzalez et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Add to Collection

Article Medicine, Research & Experimental

PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection

Loghman Salimzadeh et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Add to Collection

Article Medicine, Research & Experimental

Circulating and intrahepatic antiviral B cells are defective in hepatitis B

Alice R. Burton et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Add to Collection

Article Biotechnology & Applied Microbiology

Integration of a CD19 CAR into the. TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells

Daniel T. MacLeod et al.

MOLECULAR THERAPY (2017)

Add to Collection

Article Cell Biology

RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg

Christine I. Wooddell et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Add to Collection

Review Virology

HBV DNA Integration: Molecular Mechanisms and Clinical Implications

Thomas Tu et al.

VIRUSES-BASEL (2017)

Add to Collection

Review Gastroenterology & Hepatology

Overview of hepatitis B viral replication and genetic variability

Shuping Tong et al.

JOURNAL OF HEPATOLOGY (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Hepatitis B virus nuclear export elements: RNA stem-loop and , key parts of the HBV post-transcriptional regulatory element

Chun Shen Lim et al.

RNA BIOLOGY (2016)

Add to Collection

Article Virology

In vivo tissue-tropism of adeno-associated viral vectors

Arun Srivastava

CURRENT OPINION IN VIROLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B

Michael Nassal

GUT (2015)

Add to Collection

Article Medicine, Research & Experimental

Antiviral Therapies and Prospects for a Cure of Chronic Hepatitis B

Fabien Zoulim et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)

Add to Collection

Article Gastroenterology & Hepatology

HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability

Gi-Ae Kim et al.

GUT (2014)

Add to Collection

Article Medicine, General & Internal

Hepatitis B virus infection

Christian Trepo et al.

LANCET (2014)

Add to Collection

Article Gastroenterology & Hepatology

Prospects for inhibiting the post-transcriptional regulation of gene expression in hepatitis B virus

Augustine Chen et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

George Papatheodoridis et al.

JOURNAL OF HEPATOLOGY (2012)

Add to Collection

Editorial Material Gastroenterology & Hepatology

The replication cycle of hepatitis B virus

Stephan Urban et al.

JOURNAL OF HEPATOLOGY (2010)

Add to Collection

Review Gastroenterology & Hepatology

Regulatory elements of hepatitis B virus transcription

N Moolla et al.

JOURNAL OF VIRAL HEPATITIS (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.